The SINGLE INHALER THERAPY WITH SYMBICORT brand, founded in 2004 (Sweden), from 585 sister brands and 17478 competing brands. SINGLE INHALER THERAPY WITH SYMBICORT is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. SINGLE INHALER THERAPY WITH SYMBICORT is part of the Drug Manufacturers activity sector.